Design and Synthesis of Oligopeptidic Parvulin Inhibitors
Nicola Relitti(University of Siena), Nunzianna Doti(Institute of Biostructure and Bioimaging), Vincenzo Calderone(University of Pisa), Rosaria Benedetti(University of Campania "Luigi Vanvitelli"), Stefania Butini(University of Siena), Alessandro Papa(University of Siena), Lucia Altucci(Biogem), Alessandra Monti(Institute of Biostructure and Bioimaging), Simone Brogi(University of Pisa), Eugenia Passaro(University of Campania "Luigi Vanvitelli"), Gabriele Carullo(University of Siena), A. Prasanth Saraswati(University of Siena), Sandra Gemma(University of Siena), Giuseppe Campiani(University of Siena)
Cited by 5
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
|Cell|2016|570
Apoptotic cell death in disease—Current understanding of the NCCD 2023
|Cell Death and Differentiation|2023|371
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance
|Current Medicinal Chemistry|2017|127